Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Loading metrics

Open Access

Peer-reviewed

Research Article

Nanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian Cancer

Shailendra Giri,

Current address: Department of Neurology, Henry Ford Health System, Detroit, Michigan, United States of America

Affiliation Department of Experimental Pathology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Ajay Karakoti,

Current address: Environmental and Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, Washington, United States of America

Affiliation Mechanical Materials Aerospace Eng, Advanced Materials Processing Analysis Center, Nanoscience Technology Center, University of Central Florida, Orlando, Florida, United States of America
⨯
Rondell P. Graham,

Affiliation Anatomic/Clinical Pathology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Jacie L. Maguire,

Affiliation Department of Experimental Pathology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Christopher M. Reilly,

Affiliation Via Virginia College of Osteopathic Medicine and Virginia-Maryland Regional College of Veterinary Medicine Virginia Tech, Blacksburg Virginia, United States of America
⨯
Sudipta Seal ,

* E-mail: shridhar.vijayalakshmi@mayo.edu (VS); rrattan1@hfhs.org (RR); Sudipta.Seal@ucf.edu (SS)

Affiliation Mechanical Materials Aerospace Eng, Advanced Materials Processing Analysis Center, Nanoscience Technology Center, University of Central Florida, Orlando, Florida, United States of America
⨯
Ramandeep Rattan ,

* E-mail: shridhar.vijayalakshmi@mayo.edu (VS); rrattan1@hfhs.org (RR); Sudipta.Seal@ucf.edu (SS)

Affiliation Women’s Health Services, Henry Ford Health System, Detroit, Michigan, United States of America
⨯
Viji Shridhar

* E-mail: shridhar.vijayalakshmi@mayo.edu (VS); rrattan1@hfhs.org (RR); Sudipta.Seal@ucf.edu (SS)

Affiliation Department of Experimental Pathology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
⨯

Nanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian Cancer

Shailendra Giri,
Ajay Karakoti,
Rondell P. Graham,
Jacie L. Maguire,
Christopher M. Reilly,
Sudipta Seal,
Ramandeep Rattan,
Viji Shridhar

x

Published: January 31, 2013
https://doi.org/10.1371/journal.pone.0054578

Reader Comments (0)

Post a new comment on this article

Print

Advertisement

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Ovarian cancer
Is the Subject Area "Ovarian cancer" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Nanoparticles
Is the Subject Area "Nanoparticles" applicable to this article?

Thanks for your feedback.
Cerium
Is the Subject Area "Cerium" applicable to this article?

Thanks for your feedback.
Renal cancer
Is the Subject Area "Renal cancer" applicable to this article?

Thanks for your feedback.
Endothelial cells
Is the Subject Area "Endothelial cells" applicable to this article?

Thanks for your feedback.